Autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes. An increased understanding of the disorder's underlying genetic, molecular, and cellular mechanisms and a better appreciation of its progression and systemic manifestations have laid out the foundation for the development of clinical trials and potentially effective treatments.

[1]  V. Torres,et al.  A complete mutation screen of the ADPKD genes by DHPLC. , 2002, Kidney international.

[2]  M. Sutters,et al.  Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. , 2001, Kidney international.

[3]  Ann M. Johnson,et al.  Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease , 1990, Hepatology.

[4]  G. Germino Autosomal dominant polycystic kidney disease: a two-hit model. , 1997, Hospital practice.

[5]  V. Sukhatme,et al.  Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Somlo,et al.  Human disease: Calcium signaling in polycystic kidney disease , 2001, Current Biology.

[7]  X. Chen,et al.  Vascular expression of polycystin-2. , 1997, Journal of the American Society of Nephrology : JASN.

[8]  J. Grantham,et al.  Macropuncture study of polycystic disease in adult human kidneys. , 1980, Kidney international.

[9]  P. Green,et al.  Regional localization of the autosomal dominant polycystic kidney disease locus. , 1988, Genomics.

[10]  L. Bankir,et al.  Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. , 1990, The American journal of physiology.

[11]  K. Offord,et al.  Natriuretic response to volume expansion in polycystic kidney disease. , 1989, Mayo Clinic proceedings.

[12]  R. Ehman,et al.  Measurement of normal renal artery blood flow: cine phase-contrast MR imaging vs clearance of p-aminohippurate. , 1993, AJR. American journal of roentgenology.

[13]  J. Burnside,et al.  Cytokines in fluids from polycystic kidneys. , 1991, Kidney international.

[14]  Dalgaard Oz Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. , 1957 .

[15]  J. Lavinha,et al.  Long-term follow-up of a family with autosomal dominant polycystic kidney disease type 3. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  P. Gabow,et al.  Linkage heterogeneity of autosomal dominant polycystic kidney disease. , 1988, The New England journal of medicine.

[17]  H. Wahner,et al.  Cyst decompression surgery for autosomal dominant polycystic kidney disease. , 1992, Journal of the American Society of Nephrology : JASN.

[18]  K. Klinger,et al.  Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. , 2000, Human molecular genetics.

[19]  K P Offord,et al.  Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. , 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  T. Keith,et al.  Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1). , 1990, Journal of Medical Genetics.

[21]  Paul A Thompson,et al.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. , 2003, Kidney international.

[22]  K. Hofmann,et al.  A latrophilin/CL-1-like GPS domain in polycystin-1 , 1999, Current Biology.

[23]  C. Stayner,et al.  Polycystin channels and kidney disease. , 2001, Trends in pharmacological sciences.

[24]  S. Orellana,et al.  cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia. , 2002, American journal of physiology. Cell physiology.

[25]  Ann M. Johnson,et al.  Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. , 1994, Journal of the American Society of Nephrology : JASN.

[26]  S. Brenner,et al.  Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. , 1997, Human molecular genetics.

[27]  R. G. Walker,et al.  Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 , 1994, The Lancet.

[28]  P. Gabow,et al.  Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. , 1991, Annals of internal medicine.

[29]  P. Jungers,et al.  Is the process of urinary urea concentration responsible for a high glomerular filtration rate? , 1993, Journal of the American Society of Nephrology : JASN.

[30]  A. Paterson,et al.  Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. , 2001, American journal of human genetics.

[31]  A. Bakkaloğlu,et al.  Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. , 2001, American journal of human genetics.

[32]  L. Agodoa,et al.  Liver cysts in patients with autosomal dominant polycystic kidney disease. , 1980, The American journal of medicine.

[33]  G. A. Gillespie,et al.  The gene for autosomal dominant polycystic kidney disease lies in a 750-kb CpG-rich region. , 1992, Genomics.

[34]  K. Offord,et al.  Renal ammonia in autosomal dominant polycystic kidney disease. , 1994, Kidney international.

[35]  S. Geberth,et al.  Renal histology in polycystic kidney disease with incipient and advanced renal failure. , 1992, Kidney international.

[36]  A. Wright,et al.  Education and attitudes in families with adult polycystic kidney disease. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  J. Hughes,et al.  The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains , 1995, Nature Genetics.

[38]  L. Cooper,et al.  USRDS. 2001 Annual Data Report. , 2001, Nephrology news & issues.

[39]  H. Cantiello,et al.  Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Wilson,et al.  The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[41]  P. Ratcliffe,et al.  Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker , 1991, The Lancet.

[42]  L. Sandkuijl,et al.  Genetic heterogeneity of polycystic kidney disease in Europe. , 1992, Contributions to nephrology.

[43]  M. Breuning,et al.  Intracranial aneurysms in polycystic kidney disease linked to chromosome 4. , 1995, Journal of the American Society of Nephrology : JASN.

[44]  R. Schrier,et al.  Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. , 2001, Journal of the American Society of Nephrology : JASN.

[45]  R. T. Scheff,et al.  Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. , 1980, Annals of internal medicine.

[46]  W. Swanson,et al.  The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1 , 1996, The Journal of cell biology.

[47]  A. Paterson,et al.  Unified criteria for ultrasonographic diagnosis of ADPKD. , 2009, Journal of the American Society of Nephrology : JASN.

[48]  G. Germino,et al.  PKD1 interacts with PKD2 through a probable coiled-coil domain , 1997, Nature Genetics.

[49]  A. Evan,et al.  Cyst formation and growth in autosomal dominant polycystic kidney disease. , 1987, Kidney international.

[50]  Ann M. Johnson,et al.  Echocardiographic findings in autosomal dominant polycystic kidney disease. , 1988, The New England journal of medicine.

[51]  M. H. Gault,et al.  The diagnosis and prognosis of autosomal dominant polycystic kidney disease. , 1990, The New England journal of medicine.

[52]  R. Clayman,et al.  Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  J. Helderman,et al.  Colonic screening prior to renal transplantation and its impact on post-transplant colonic complications. , 1992, Clinical transplantation.

[54]  D. Earle Bilateral Polycystic Disease of the Kidneys: A Follow-Up of Two Hundred and Eighty-Four Patients and Their Families. , 1958 .

[55]  Ann M. Johnson,et al.  Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. , 1990, American journal of medical genetics.

[56]  P. Gabow Autosomal dominant polycystic kidney disease. , 2010, The New England journal of medicine.

[57]  J. Kassirer,et al.  Occult intracranial aneurysms in polycystic kidney disease. When is cerebral arteriography indicated? , 1983, The New England journal of medicine.

[58]  A. Sawyer-Glover,et al.  Renal blood flow: measurement in vivo with rapid spiral MR imaging. , 1998, Radiology.

[59]  C. Chothia,et al.  The structure of a PKD domain from polycystin‐1: implications for polycystic kidney disease , 1999, The EMBO journal.

[60]  P. Gabow,et al.  Prediction of Likelihood of Polycystic Kidney Disease in the Fetus When a Parent has Autosomal Dominant Polycystic Kidney Disease , 1991 .

[61]  U. Francke,et al.  Chromosomal localization of human Na+,K+-ATPase α- and β-subunit genes , 1988 .

[62]  G. Germino,et al.  Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. , 2001, Journal of the American Society of Nephrology : JASN.

[63]  V. Torres,et al.  Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[64]  X. Estivill,et al.  Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. , 1996, Journal of the American Society of Nephrology : JASN.

[65]  V. Torres,et al.  Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. , 2002, Journal of the American Society of Nephrology : JASN.

[66]  D. Woo,et al.  Apoptosis and loss of renal tissue in polycystic kidney diseases. , 1995, The New England journal of medicine.

[67]  A. Evan,et al.  Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic disease. , 1979, Kidney international.

[68]  V. Torres,et al.  Vascular expression of polycystin. , 1997, Journal of the American Society of Nephrology : JASN.

[69]  K. Offord,et al.  Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. , 1991, Mayo Clinic proceedings.

[70]  P. Allan,et al.  Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. , 1992, Kidney international.

[71]  P. Gabow Polycystic kidney disease: clues to pathogenesis. , 1991, Kidney international.

[72]  G. A. Gillespie,et al.  Fine genetic localization of the gene for autosomal dominant polycystic kidney disease (PKD1) with respect to physically mapped markers. , 1992, Genomics.

[73]  V. Torres,et al.  Renal stone disease in autosomal dominant polycystic kidney disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  Ann M. Johnson,et al.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. , 1992 .

[75]  E. Brown,et al.  Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. , 2001, Biochemical and biophysical research communications.

[76]  K. Keven,et al.  The safety of gadolinium in patients with stage 3 and 4 renal failure. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[77]  P. Rust,et al.  Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[78]  A. Donker,et al.  Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. , 1996, Journal of the American Society of Nephrology : JASN.

[79]  R. Timpl,et al.  Role of laminin a chain in the development of epithelial cell polarity , 1988, Cell.

[80]  L. Baert,et al.  Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. , 1978, Kidney international.

[81]  V. Torres,et al.  The association of nephrolithiasis and autosomal dominant polycystic kidney disease. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[82]  D. Peters,et al.  Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family , 1995, Human Genetics.

[83]  Ann M. Johnson,et al.  The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. , 1990, The New England journal of medicine.

[84]  G. Beck,et al.  Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. , 1995, Journal of the American Society of Nephrology : JASN.

[85]  C. Leier,et al.  Cardiovascular abnormalities associated with adult polycystic kidney disease. , 1984, Annals of internal medicine.

[86]  Y. Shugart,et al.  Segregation analysis of autosomal dominant polycystic kidney disease , 1993, Genetic epidemiology.

[87]  K. Zerres,et al.  Autosomal recessive polycystic kidney disease , 1992, The clinical investigator.

[88]  L P Sullivan,et al.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. , 2000, Kidney international.

[89]  Y Huan,et al.  Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. , 1999, The Journal of clinical investigation.

[90]  M. Adams,et al.  Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. , 1999, Genomics.

[91]  R. Perrone In vitro function of cyst epithelium from human polycystic kidney. , 1985, The Journal of clinical investigation.

[92]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[93]  S. Somlo,et al.  Evidence for a third genetic locus for autosomal dominant polycystic kidney disease , 1996, Pediatric Nephrology.

[94]  A. Telenti,et al.  Hepatic cyst infection in autosomal dominant polycystic kidney disease. , 1990, Mayo Clinic proceedings.

[95]  A. Scherzinger,et al.  Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease , 1997, Hepatology.

[96]  G. Brosnahan,et al.  Volume progression in polycystic kidney disease. , 2006, The New England journal of medicine.

[97]  K. Bae,et al.  MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[98]  M. Breuning,et al.  Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. , 2000, Human molecular genetics.

[99]  G. Germino,et al.  The Molecular Basis of Focal Cyst Formation in Human Autosomal Dominant Polycystic Kidney Disease Type I , 1996, Cell.

[100]  J. Mcateer,et al.  Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. , 1992, Kidney international.

[101]  Oliver Senn,et al.  Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. , 2009, Kidney international.

[102]  P. Courtoy,et al.  Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[103]  Ann M. Johnson,et al.  Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. , 1997, Journal of the American Society of Nephrology : JASN.

[104]  Y. Ubara,et al.  Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[105]  R. Torra,et al.  Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. , 1999, Radiology.

[106]  D. Nagorney,et al.  Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. , 1995, Gastroenterology.

[107]  B. Gross,et al.  Seminal vesicle cysts: association with adult polycystic kidney disease. , 1991, Radiology.

[108]  L. Agodoa,et al.  Autosomal dominant polycystic kidney disease: symptoms and clinical findings. , 1984, The Quarterly journal of medicine.

[109]  P. Jungers,et al.  Liver changes and complications in adult polycystic kidney disease. , 1985, Advances in nephrology from the Necker Hospital.

[110]  J. Grantham Pathogenesis of autosomal dominant polycystic kidney disease: recent developments. , 1997, Contributions to nephrology.

[111]  V. Torres Polycystic liver disease. , 1995, Contributions to nephrology.

[112]  W. Guggino,et al.  cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. , 2000, Journal of the American Society of Nephrology : JASN.

[113]  V. Vacquier,et al.  suREJ3, a Polycystin-1 Protein, Is Cleaved at the GPS Domain and Localizes to the Acrosomal Region of Sea Urchin Sperm* , 2002, The Journal of Biological Chemistry.

[114]  K. Davies,et al.  A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16 , 1985, Nature.

[115]  F. Windmeijer,et al.  R-Squared Measures for Count Data Regression Models With Applications to Health-Care Utilization , 1996 .

[116]  M. Arnaout,et al.  Polycystin-1 Interacts with Intermediate Filaments* , 2001, The Journal of Biological Chemistry.

[117]  A. Stanson,et al.  Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. , 1994, Journal of the American Society of Nephrology : JASN.

[118]  V. Torres,et al.  Treatment prospects for autosomal-dominant polycystic kidney disease. , 2001, Kidney international.

[119]  D. Wallace,et al.  Chloride and fluid secretion in polycystic kidney disease. , 1998, Journal of the American Society of Nephrology : JASN.

[120]  P. Wilson,et al.  A role for CFTR in human autosomal dominant polycystic kidney disease. , 1996, The American journal of physiology.

[121]  E. Coto,et al.  Comparison of phenotypes of polycystic kidney disease types 1 and 2 , 1999, The Lancet.

[122]  A. Donker,et al.  Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. , 1989, Kidney international. Supplement.

[123]  R. Gibson,et al.  An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[124]  G. Lindop,et al.  The anatomy of the renin-secreting cell in adult polycystic kidney disease. , 1988, Kidney international.

[125]  T. Okamoto,et al.  The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. , 1998, Biochemical and biophysical research communications.

[126]  Ann M. Johnson,et al.  Characteristics of very early onset autosomal dominant polycystic kidney disease , 1993, Pediatric Nephrology.

[127]  Ann M. Johnson,et al.  Renal structure and hypertension in autosomal dominant polycystic kidney disease. , 1990, Kidney international.

[128]  S. Geberth,et al.  Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[129]  Patricia A. Gabow,et al.  PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.

[130]  K. Gardner Composition of fluid in twelve cysts of a polycystic kidney. , 1969, The New England journal of medicine.

[131]  A. Williams,et al.  Polycystic kidney disease re-evaluated: a population-based study. , 1991, The Quarterly journal of medicine.

[132]  L. Agodoa,et al.  Fertility and Pregnancy Complications in Women With Autosomal Dominant Polycystic Kidney Disease , 1983, Obstetrics and gynecology.

[133]  P. Gabow,et al.  Intra- and extracellular proteins in human normal and polycystic kidney epithelial cells. , 1990, Kidney international.

[134]  K. Zerres,et al.  Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie. , 1993, Journal of medical genetics.